Bellevue Group AG Has $41.17 Million Holdings in Inspire Medical Systems, Inc. (NYSE:INSP)

Bellevue Group AG grew its stake in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 56.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 195,080 shares of the company's stock after purchasing an additional 70,356 shares during the period. Bellevue Group AG owned approximately 0.65% of Inspire Medical Systems worth $41,172,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of the stock. Wasatch Advisors LP grew its stake in Inspire Medical Systems by 1.6% during the third quarter. Wasatch Advisors LP now owns 1,323,470 shares of the company's stock worth $279,318,000 after buying an additional 20,481 shares during the last quarter. Bank of New York Mellon Corp grew its position in Inspire Medical Systems by 32.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 787,815 shares of the company's stock worth $105,433,000 after acquiring an additional 192,238 shares during the last quarter. William Blair Investment Management LLC increased its holdings in Inspire Medical Systems by 1.8% during the 2nd quarter. William Blair Investment Management LLC now owns 770,413 shares of the company's stock valued at $103,104,000 after purchasing an additional 13,602 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in Inspire Medical Systems by 4.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 281,165 shares of the company's stock valued at $59,340,000 after purchasing an additional 11,939 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC raised its position in Inspire Medical Systems by 798.3% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 267,852 shares of the company's stock valued at $56,530,000 after purchasing an additional 238,034 shares during the last quarter. 94.91% of the stock is owned by institutional investors and hedge funds.

Inspire Medical Systems Price Performance

Shares of Inspire Medical Systems stock traded down $1.24 during trading on Friday, hitting $192.76. 261,447 shares of the company were exchanged, compared to its average volume of 605,606. The firm has a market capitalization of $5.78 billion, a P/E ratio of 180.15 and a beta of 1.36. The firm's fifty day moving average price is $197.96 and its 200 day moving average price is $176.33. Inspire Medical Systems, Inc. has a 1-year low of $123.00 and a 1-year high of $257.40.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last released its quarterly earnings data on Monday, November 4th. The company reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.54. The business had revenue of $203.20 million for the quarter, compared to analysts' expectations of $197.59 million. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. Inspire Medical Systems's revenue for the quarter was up 32.6% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.29) EPS. As a group, equities research analysts anticipate that Inspire Medical Systems, Inc. will post 1.33 earnings per share for the current year.

Analyst Upgrades and Downgrades

INSP has been the subject of a number of research reports. Royal Bank of Canada restated an "outperform" rating and issued a $260.00 target price on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Piper Sandler restated an "overweight" rating and issued a $260.00 price objective (up previously from $255.00) on shares of Inspire Medical Systems in a research report on Tuesday, November 5th. KeyCorp reduced their target price on shares of Inspire Medical Systems from $278.00 to $236.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 7th. Stifel Nicolaus reaffirmed a "hold" rating and set a $200.00 price objective (up previously from $170.00) on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Finally, Truist Financial reissued a "buy" rating and issued a $240.00 target price (up from $217.00) on shares of Inspire Medical Systems in a research note on Monday, September 30th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat, Inspire Medical Systems currently has an average rating of "Moderate Buy" and a consensus target price of $233.58.

Insider Transactions at Inspire Medical Systems

In other Inspire Medical Systems news, Director Shawn Mccormick sold 800 shares of Inspire Medical Systems stock in a transaction on Monday, September 9th. The shares were sold at an average price of $220.00, for a total value of $176,000.00. Following the sale, the director now directly owns 23,140 shares in the company, valued at approximately $5,090,800. The trade was a 3.34 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 4.10% of the stock is owned by insiders.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.